Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
facet life sciences
Articles
1
From
2026-08-04 07:38:14+00
To
2026-08-04 07:38:14+00
Range
2026-07-05 16:12:54.943966+00 →
2026-08-04 16:12:54.943966+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| accelerated approval | ORG | 1 | 📊 🔍 🧲 |
| adcom | PRODUCT | 1 | 📊 🔍 🧲 |
| adcoms | ORG | 1 | 📊 🔍 🧲 |
| ai readiness starts | ORG | 1 | 📊 🔍 🧲 |
| annex clinical corporation | ORG | 1 | 📊 🔍 🧲 |
| biospace | ORG | 1 | 📊 🔍 🧲 |
| bla | ORG | 1 | 📊 🔍 🧲 |
| capricor | ORG | 1 | 📊 🔍 🧲 |
| capricor therapeutics | PERSON | 1 | 📊 🔍 🧲 |
| cfr | ORG | 1 | 📊 🔍 🧲 |
| chaotic adcomm meeting | ORG | 1 | 📊 🔍 🧲 |
| clinibiz | ORG | 1 | 📊 🔍 🧲 |
| complete response letter for capricors biologics license application | ORG | 1 | 📊 🔍 🧲 |
| controls | NORP | 1 | 📊 🔍 🧲 |
| crl | ORG | 1 | 📊 🔍 🧲 |
| ctgtac | ORG | 1 | 📊 🔍 🧲 |
| deramiocel briefing | PERSON | 1 | 📊 🔍 🧲 |
| duchenne | PERSON | 1 | 📊 🔍 🧲 |
| facet life sciences | ORG | 1 | 📊 🔍 🧲 |
| fda | ORG | 1 | 📊 🔍 🧲 |
| fda accelerated | ORG | 1 | 📊 🔍 🧲 |
| fda adcom shuns capricors | ORG | 1 | 📊 🔍 🧲 |
| fda advisers vote against approval | ORG | 1 | 📊 🔍 🧲 |
| fda advisory committee statistical analysis | ORG | 1 | 📊 🔍 🧲 |
| fda advisory panel votes against approval of | ORG | 1 | 📊 🔍 🧲 |
Who’s talking
Top Sources (Domains)
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 100.00 | 📊 📰 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-08-04 07:38:14+00 | Science |
|
Capricor’s Duchenne AdCom Didn’t Fail on Science. It Failed on Statistics. | Analyze | Moe Alsumidaie | 😐 neutral | 0.0249 |